Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
Go back to Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment| (NASDAQ: ACON) | Delayed: 2.25 -0.09 (3.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.34 | 52 Week High | $ | |||
| Open | $2.34 | 52 Week Low | $ | |||
| Day High | $2.35 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $ | |||
| Volume | 26,982 | |||||
| (NASDAQ: ACONW) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 25,430 | |||||



